Characterisation of the enzyme intermediates of the sarcoplasmic transport ATPase by the use of inhibitors.
1. Based on a detailed reaction scheme of the phosphorylation process of the sarcoplasmic transport ATPase the inhibition mechanisms of benzoctamine, DIO 9, AMP-PNP and of Ca2+-ions at relatively high concentrations (1 approximately 100 microM) were determined. 2. The inhibition mechanisms were analyzed by measuring the gamma-phosphate exchange between ATP and ADP and evaluated by applying conventional and an extended Dixon plot procedures. 3. The kinetic patterns of the inhibition were shown to be compatible with the assumed reaction scheme. 4. Each inhibitor combines with definite intermediates: Benzoctamine with the intermediate species Ca2MgE and Ca2Mg2E-ATP; AMP-PNP with Ca2Mg2E approximately P; DIO 9 with E and MgE and Ca2+ at relatively high concentrations with E. 5. The central intermediate blocked by benzoctamine can partially exist as Ca2Mg2E ADPP-benzoctamine which is detected as phosphoprotein after acid denaturation.
D000818:Animals; D000252:Calcium-Transporting ATPases / Q000378:metabolism*; D007700:Kinetics; D008433:Mathematics; D000226:Mitochondrial ADP, ATP Translocases / Q000378:metabolism*; D009132:Muscles / Q000201:enzymology; D009713:Nucleotidyltransferases / Q000378:metabolism*; D011817:Rabbits; D012519:Sarcoplasmic Reticulum / Q000201:enzymology*
D000226:Mitochondrial ADP, ATP Translocases; D009713:Nucleotidyltransferases; D000252:Calcium-Transporting ATPases